{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:33:17Z","timestamp":1781026397968,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although acute hepatitis E is not fatal in healthy individuals, it is unclear whether hepatitis E superinfection increases the mortality in patients with pre-existing liver disease. Thus, we investigated the prognosis of patients with acute hepatitis E according to their cirrhosis diagnosis, and the prognosis according to the development of acute-on-chronic liver failure (ACLF) in patients with cirrhosis and chronic liver disease (CLD).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 74 consecutive patients who were diagnosed with acute viral hepatitis E between January 2007 and December 2019. Of them, 39 patients without CLD, 13 patients with non-cirrhotic CLD, and 22 patients with cirrhotic CLD were analyzed.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 74 patients with HEV infection, 7 (9.5%) died within 180\u00a0days: 5 with underlying cirrhosis (71.4%) and 2 without cirrhosis (28.6%). The 180-day mortality was significant higher for patients with cirrhosis than for patients without cirrhosis (22.7% vs. 3.8%, <jats:italic>P<\/jats:italic>\u2009=\u20090.013). The age- and sex-adjusted proportional-hazard model revealed an approximately eightfold increase in the 180-day mortality risk in patients with cirrhosis compared to patients without cirrhosis. In addition, development of hepatitis E virus-related ACLF due to acute liver function deterioration in patients with pre-existing CLD or cirrhosis worsened the 180-day mortality rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that the acute hepatitis E mortality rate was low in healthy individuals but higher in patients with cirrhosis, and especially high in those with ACLF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07050-w","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T16:06:26Z","timestamp":1642521986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Acute hepatitis E virus superinfection increases mortality in patients with cirrhosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jung Woo","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hankyu","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Kyu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra Ri","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon Tae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"4","key":"7050_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/hep.25505","volume":"55","author":"DB Rein","year":"2012","unstructured":"Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988\u201397.","journal-title":"Hepatology"},{"issue":"9956","key":"7050_CR2","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","volume":"384","author":"PE Hewitt","year":"2014","unstructured":"Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384(9956):1766\u201373.","journal-title":"Lancet"},{"key":"7050_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijid.2017.05.014","volume":"61","author":"M Bura","year":"2017","unstructured":"Bura M, Lagiedo M, Michalak M, Sikora J, Mozer-Lisewska I. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland. Int J Infect Dis. 2017;61:20\u20132.","journal-title":"Int J Infect Dis"},{"key":"7050_CR4","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L: EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018; 68(6):1256\u201371."},{"issue":"13","key":"7050_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJMra1204512","volume":"367","author":"JH Hoofnagle","year":"2012","unstructured":"Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012;367(13):1237\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"7050_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.28436","volume":"63","author":"JM Mansuy","year":"2016","unstructured":"Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology. 2016;63(4):1145\u201354.","journal-title":"Hepatology"},{"issue":"4","key":"7050_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5009\/gnl.2011.5.4.427","volume":"5","author":"SH Jeong","year":"2011","unstructured":"Jeong SH. Current status of hepatitis e virus infection in Korea. Gut Liver. 2011;5(4):427\u201331.","journal-title":"Gut Liver"},{"issue":"3","key":"7050_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000480506","volume":"60","author":"HW Oh","year":"2017","unstructured":"Oh HW, Cha RR, Lee SS, Lee CM, Kim WS, Jo YW, et al. Comparing the clinical features and outcomes of acute hepatitis E viral infections with those of acute hepatitis A, B, and C infections in Korea. Intervirology. 2017;60(3):109\u201317.","journal-title":"Intervirology"},{"issue":"3","key":"7050_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jhep.2006.09.016","volume":"46","author":"S Kumar Acharya","year":"2007","unstructured":"Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, Kumar Jha J, Kumar Panda S. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46(3):387\u201394.","journal-title":"J Hepatol"},{"issue":"2","key":"7050_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/jhep.2002.34856","volume":"36","author":"SS Hamid","year":"2002","unstructured":"Hamid SS, Atiq M, Shehzad F, Yasmeen A, Nissa T, Salam A, Siddiqui A, Jafri W. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology. 2002;36(2):474\u20138.","journal-title":"Hepatology"},{"issue":"3","key":"7050_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jceh.2013.08.013","volume":"3","author":"A Kumar","year":"2013","unstructured":"Kumar A, Saraswat VA. Hepatitis E and acute-on-chronic liver failure. J Clin Exp Hepatol. 2013;3(3):225\u201330.","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"7050_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353\u201390.","journal-title":"Hepatol Int"},{"issue":"5","key":"7050_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/apt.13309","volume":"42","author":"H Blasco-Perrin","year":"2015","unstructured":"Blasco-Perrin H, Madden RG, Stanley A, Crossan C, Hunter JG, Vine L, et al. Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK\/French study. Aliment Pharmacol Ther. 2015;42(5):574\u201381.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"7050_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcv.2010.11.005","volume":"50","author":"YM Kim","year":"2011","unstructured":"Kim YM, Jeong SH, Kim JY, Song JC, Lee JH, Kim JW, Yun H, Kim JS. The first case of genotype 4 hepatitis E related to wild boar in South Korea. J Clin Virol. 2011;50(3):253\u20136.","journal-title":"J Clin Virol"},{"issue":"6","key":"7050_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00705-010-0661-9","volume":"155","author":"H Yun","year":"2010","unstructured":"Yun H, Kim JS, Lee HJ, Jeong SH, Kim JS, Park SJ, et al. The complete genome sequence and molecular analysis of human hepatitis E virus genotype IV identified from a Korean patient. Arch Virol. 2010;155(6):1003\u20138.","journal-title":"Arch Virol"},{"issue":"3","key":"7050_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3350\/cmh.2013.19.3.309","volume":"19","author":"JY Choi","year":"2013","unstructured":"Choi JY, Lee JM, Jo YW, Min HJ, Kim HJ, Jung WT, Lee OJ, Yun H, Yoon YS. Genotype-4 hepatitis E in a human after ingesting roe deer meat in South Korea. Clin Mol Hepatol. 2013;19(3):309\u201314.","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"7050_CR17","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426\u201337.","journal-title":"Gastroenterology"},{"issue":"5","key":"7050_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Gines P, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038\u201347.","journal-title":"J Hepatol"},{"issue":"6","key":"7050_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s12072-019-09980-1","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(6):826\u20138.","journal-title":"Hepatol Int"},{"issue":"4","key":"7050_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology. 2016;150(4):785\u201390.","journal-title":"Gastroenterology"},{"issue":"2","key":"7050_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1440-1746.2004.03188.x","volume":"19","author":"J Ramachandran","year":"2004","unstructured":"Ramachandran J, Eapen CE, Kang G, Abraham P, Hubert DD, Kurian G, Hephzibah J, Mukhopadhya A, Chandy GM. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol. 2004;19(2):134\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9569","key":"7050_CR22","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(07)60595-9","volume":"369","author":"HR Dalton","year":"2007","unstructured":"Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet. 2007;369(9569):1260.","journal-title":"Lancet"},{"issue":"5","key":"7050_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2893.2007.00858.x","volume":"14","author":"JM Peron","year":"2007","unstructured":"Peron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, Dupuis E, Izopet J, Vinel JP. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14(5):298\u2013303.","journal-title":"J Viral Hepat"},{"issue":"35","key":"7050_CR24","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.3748\/wjg.v19.i35.5904","volume":"19","author":"SH Cheng","year":"2013","unstructured":"Cheng SH, Mai L, Zhu FQ, Pan XF, Sun HX, Cao H, et al. Influence of chronic HBV infection on superimposed acute hepatitis E. World J Gastroenterol. 2013;19(35):5904\u20139.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"7050_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12072-010-9204-4","volume":"4","author":"X Zhang","year":"2010","unstructured":"Zhang X, Ke W, Xie J, Zhao Z, Xie D, Gao Z. Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B. Hepatol Int. 2010;4(3):615\u201320.","journal-title":"Hepatol Int"},{"issue":"9835","key":"7050_CR26","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"N Kamar","year":"2012","unstructured":"Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Hepatitis E. Lancet. 2012;379(9835):2477\u201388.","journal-title":"Lancet"},{"issue":"4","key":"7050_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ofid\/ofaa107","volume":"7","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu H, Jiang Y, Pan Q, Zhao J. Poor outcomes of acute hepatitis E in patients with cirrhotic liver diseases regardless of etiology. Open Forum Infect Dis. 2020;7(4):107.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"7050_CR28","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/cid\/ciy234","volume":"67","author":"JC Lai","year":"2018","unstructured":"Lai JC, Wong GL, Yip TC, Tse YK, Lam KL, Lui GC, Chan HL, Wong VW. Chronic hepatitis B increases liver-related mortality of patients with acute hepatitis E: a territorywide cohort study from 2000 to 2016. Clin Infect Dis. 2018;67(8):1278\u201384.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"7050_CR29","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/cid\/ciz724","volume":"70","author":"L Sun","year":"2020","unstructured":"Sun L, Fan J, Gao H, Shan L, Li X, Zhuang H, Fan H. Clinical outcomes in patients with acute hepatitis E: exacerbation by background end-stage liver disease but not pure hepatitis B virus infection. Clin Infect Dis. 2020;70(12):2747\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"7050_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jhep.2020.01.012","volume":"72","author":"TC Tseng","year":"2020","unstructured":"Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, et al. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. J Hepatol. 2020;72(6):1105\u201311.","journal-title":"J Hepatol"},{"key":"7050_CR31","first-page":"9098535","volume":"2018","author":"M Frias","year":"2018","unstructured":"Frias M, Lopez-Lopez P, Rivero A, Rivero-Juarez A. Role of hepatitis E virus infection in acute-on-chronic liver failure. Biomed Res Int. 2018;2018:9098535.","journal-title":"Biomed Res Int"},{"issue":"Suppl","key":"7050_CR32","first-page":"71","volume":"45","author":"SS Naidu","year":"1957","unstructured":"Naidu SS, Viswanathan R. Infectious hepatitis in pregnancy during Delhi epidemic. Indian J Med Res. 1957;45(Suppl):71\u20136.","journal-title":"Indian J Med Res"},{"issue":"5","key":"7050_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","volume":"74","author":"J Trebicka","year":"2021","unstructured":"Trebicka J, Fernandez J, Papp M, Caraceni P, Laleman W, Gambino C, et al. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. J Hepatol. 2021;74(5):1097\u2013108.","journal-title":"J Hepatol"},{"key":"7050_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2334-12-142","volume":"12","author":"HK Park","year":"2012","unstructured":"Park HK, Jeong SH, Kim JW, Woo BH, Lee DH, Kim HY, Ahn S. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis. 2012;12:142.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07050-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07050-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07050-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T16:07:27Z","timestamp":1642522047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07050-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7050"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07050-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"24 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Institutional Review Board of Gyeongsang National University Changwon Hospital (IRB File No. 2018-07-009) and Gyeongsang National University Hospital (IRB File No. 2014-04-028) Informed consent was waived given that all of the personal data obtained were anonymized before analysis, as determined by the Institutional Review Boards of Gyeongsang National University Changwon Hospital and Gyeongsang National University Hospital. All methods in this study were performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}